✦ LIBER ✦

Immunosuppressive Therapy with Oral Prednisone to Prevent Restenosis after PCI. A Multicenter Randomized Trial

✍ Scribed by Flavio Ribichini; Fabrizio Tomai; Giuseppe De Luca; Giacomo Boccuzzi; Patrizia Presbitero; Gabriele Pesarini; Valeria Ferrero; Anna S. Ghini; Ramadan Abukaresh; Cristina Aurigemma; Leonardo De Luca; Dennis Zavalloni; Daniela Soregaroli; Paolo Marino; Roberto Garbo; Luisa Zanolla; Corrado Vassanelli

Book ID: 116212980
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 647 KB
Volume: 124
Category: Article
ISSN: 1555-7162
DOI: 10.1016/j.amjmed.2010.11.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-841 ORAl iMmunosuppressive therapy t

TCT-841 ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trials

✍ Cassese, Salvatore; De Luca, Giuseppe; Ribichini, Flavio L.; Cernigliaro, Carmel 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Long-term clinical follow-up of the mult

Long-term clinical follow-up of the multicentre, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: Cortisone plus BMS or DES veRsus BMS alone to EliminAte Restenosis (CEREA-DES)

✍ Ribichini, F.; Tomai, F.; Pesarini, G.; Zivelonghi, C.; Rognoni, A.; De Luca, G. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 376 KB

222 oral A phase 3 randomized controlled

222 oral A phase 3 randomized controlled trial to evaluate external beam radiotherapy for the prevention of restenosis after femoropopliteal artery angioplast

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Ability of prolonged interferon treatmen

Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial

✍ Akinori Kasahara; Norio Hayashi; Naoki Hiramatsu; Masahide Oshita; Hideki Hagiwa 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 882 KB

The aim of this study was to determine whether 12 months course of interferon alfa (IFN-a) therapy could improve the beneficial effect of IFN in chronic hepatitis C. Eighty-eight patients were treated with natural IFNa for either 28 weeks (45 cases) or 52 weeks (43 cases). Sustained response was ach

Ability of prolonged interferon treatmen

Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial

✍ KASAHARA, A 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 907 KB

A Randomized, Double-Blind, Multicenter

A Randomized, Double-Blind, Multicenter Comparison Study of Triple Antiplatelet Therapy With Dual Antiplatelet Therapy to Reduce Restenosis After Drug-Eluting Stent Implantation in Long Coronary Lesions: Results From the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) Trial

✍ Seung-Whan Lee; Seong-Wook Park; Young-Hak Kim; Sung-Cheol Yun; Duk-Woo Park; Ch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 653 KB